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Background: High-frequency heart rate variability (HF-HRV) is a measure of
parasympathetic nervous system (PNS) output that has been associated with enhanced
self-regulation. Low resting levels of HF-HRV are associated with nicotine dependence
and blunted stress-related changes in HF-HRV are associated with decreased ability
to resist smoking. Meditation has been shown to increase HF-HRV. However, it
is unknown whether tonic levels of HF-HRV or acute changes in HF-HRV during
meditation predict treatment responses in addictive behaviors such as smoking cessation.
Purpose: To investigate the relationship between HF-HRV and subsequent smoking
outcomes. Methods: HF-HRV during resting baseline and during mindfulness meditation
was measured within two weeks of completing a 4-week smoking cessation intervention
in a sample of 31 community participants. Self-report measures of smoking were obtained
at a follow up 17-weeks after the initiation of treatment. Results: Regression analyses
indicated that individuals exhibiting acute increases in HF-HRV from resting baseline
to meditation smoked fewer cigarettes at follow-up than those who exhibited acute
decreases in HF-HRV (b = −4.89, p = 0.008). Conclusion: Acute changes in HF-HRV in
response to meditation may be a useful tool to predict smoking cessation treatment
response.
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The rhythm of a healthy human heart naturally fluctuates. This
normal variability in heart rate occurs, in part, from the synergis-
tic actions of the sympathetic and parasympathetic branches of
the autonomic nervous system (ANS), which act through various
neural and physiological mechanisms to allow the cardiovascular
system to adapt and respond appropriately to varying internal and
external demands and conditions (McDonald, 1980; Berntson
et al., 1993a,b, 1997). Fluctuations that occur in the 0.15 to
0.4 hertz (Hz) frequency range are a result of Respiratory Sinus
Arrhythmia (RSA), the increase and decrease in heart rate that
occurs with inhalation and exhalation, respectively, and are asso-
ciated with parasympathetic nervous system (PNS) activity via
efferent traffic in the vagus (10th cranial) nerve (Berntson et al.,
1993b). High-frequency heart rate variability (HF-HRV) is amea-
sure of the fluctuations in this frequency range and is a reliable
measure of PNS activity (Task Force, 1996; Berntson et al., 1997).
Low PNS activity, as reflected in low levels of HF-HRV, is a
marker of poor psychological health. Low resting levels of HF-
HRV measured over a few minutes and low HF-HRV over the
course of 24 h, has been associated with nicotine dependence
(Gallagher et al., 1992; Kupari et al., 1993), as well as with
trait negative affect including hostility, depression, and anxiety
(Fuller, 1992; Sloan et al., 1994; Light et al., 1998; Bleil et al.,
Abbreviations: HF-HRV, high-frequency heart rate variability; RSA, respiratory
sinus arrhythmia
2008), and a variety of affective and anxiety disorders includ-
ing major depression (Rechlin et al., 1994; Nahshoni et al., 2004;
Carney et al., 2005), bipolar disorder (Cohen et al., 2003), gen-
eralized anxiety disorder (Thayer et al., 1996), panic disorder
(Friedman and Thayer, 1998) and post-traumatic stress disor-
der (Cohen et al., 1997). High HF-HRV, on the other hand has
been associated with smoking abstinence (Minami et al., 1999),
positive emotions and interpersonal connectedness (McCraty
et al., 1995; Oveis et al., 2009; Kok and Fredrickson, 2010),
and regulated emotional responding (Appelhans and Luecken,
2006). Higher levels of HF-HRV during sleep have also been
prospectively linked with response to panic disorder treatment
(Craske et al., 2005).
Acute changes in HF-HRV are also associated with psycho-
logical conditions. In healthy individuals, acute withdrawal of
vagal efferent activity occurs in response to stressful situations
(Berntson et al., 1994), worry (Thayer et al., 1996), and induction
of negative affect (Lane et al., 2009), resulting in acute increases
in heart rate (Berntson et al., 1993b), and acute decreases in HF-
HRV. Blunted HF-HRV reactivity (smaller acute decreases) in
response to stressful events, on the other hand, has been found
in individuals with borderline personality disorder (Weinberg
et al., 2009), post-traumatic stress disorder (Cohen et al., 1998
#1001) and depression (Rottenberg et al., 2007), and may reflect
deficits in self-regulation (Segerstrom and Nes, 2007; Thayer
et al., 2009). This aberrant HF-HRV reactivity may predict
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treatment outcome; for example, depressed persons who exhib-
ited a greater degree of HF-HRV reactivity to a sad film were
more likely to recover from depression than those with blunted
reactivity (Rottenberg et al., 2005). In addition, greater HF-HRV
reactivity in children, in response to stress, has been shown to
protect against the development of psychopathology (El-Sheikh,
2001), while blunted reactivity has been shown to predict future
behavioral problems (Porges, 1996).
In healthy individuals, acute increases in HF-HRV generally
occur in response to positive-emotion induction (McCraty et al.,
1995), relaxation exercises (Sakakibara et al., 1994; Sarang and
Telles, 2006), and meditation (Lehrer et al., 1999; Takahashi
et al., 2005; Ditto et al., 2006; Peressutti et al., 2010). However,
studies have shown that there is inter-individual variability in
autonomic responses to these manipulations. For example, stud-
ies have found that some individuals exhibit acute increases in
HF-HRV when practicing mindfulness meditations, while other
exhibit acute decreases in HF-HRV (Lehrer et al., 1999; Takahashi
et al., 2005; Peressutti et al., 2010). Further, these differences may
be associated with risk factors for psychopathology. For exam-
ple, in one study involving a sample of 22 undergraduates, half of
the participants exhibited increases, and half exhibited decreases
in HF-HRV during a compassion-imagery procedure; decreases
in HF-HRV, compared to increases, were associated with self-
criticism and anxious attachment style in this otherwise healthy
sample (Rockliff et al., 2008). There have been no published stud-
ies, however, examining whether differences in HF-HRV changes
from resting baseline to meditation are prospectively related to
clinical outcomes.
The association between HF-HRV and psychological function-
ing may be a function of the relationship between HF-HRV and
self-regulation. HF-HRVmay index an individual’s ability to exert
top-down behavioral control via inhibitory processes (Thayer
and Lane, 2000). Accordingly, elevated HF-HRV is associated
with greater cognitive performance (Hansen et al., 2004; Thayer
et al., 2009), better regulation of affect during daily stress (Fabes
and Eisenberg, 1997), better modulation of emotional expression
(Demaree et al., 2002), better modulation of defensive reactions
(Ruiz-Padial et al., 2003), better attention regulation (Johnsen
et al., 2003), effective impulse control (Allen et al., 2000), and
behavioral regulation (Segerstrom and Nes, 2007). The associa-
tion between HF-HRV and self-regulation is also supported by
evidence showing that the brain structures that regulate auto-
nomic balance overlap with the networks that serve executive,
social, affective, attentional, and motivational behaviors (Thayer
and Lane, 2000; Thayer and Brosschot, 2005). Higher tonic lev-
els and context-appropriate changes in HF-HRV, then, may be
indicative of enhanced emotional and attention regulation abil-
ities (Appelhans and Luecken, 2006), while reduced HF-HRV
across situations may be indicative of a lack of emotional and
autonomic flexibility that is necessary for healthy psychological
and physiological functioning (Rozanski and Kubzansky, 2005;
Friedman, 2007).
Psychological interventions that improve emotion regula-
tion and attention regulation may result in improved ANS
functioning. Mindfulness meditation, for example, is associ-
ated with improved cognitive flexibility (Moore and Malinowski,
2009), reduced affective reactivity and greater emotion regula-
tion (Broderick, 2005; Arch and Craske, 2006; Farb et al., 2010;
Goldin and Gross, 2010) as well as improved performance on
tests of processing speed, workingmemory, and attention (Zeidan
et al., 2010a). Interestingly, research has suggested that individu-
als can be trained to be mindful in a relatively short timeframe,
although there appears to be individual variability therein. A
recent study found that novices accumulating an average of just
over 6 h of practice over the course of five weeks exhibited a signif-
icant shift in frontal EEG asymmetry toward a pattern associated
with positive, approach-oriented emotions (Moyer et al., 2011).
Decreases in amygdala activity in response to both positive and
negative emotion-inducing stimuli were found in novice medita-
tors with only 20min of practice each day for one week (Taylor
et al., 2011). Further, three 20-min training sessions over the
course of three days resulted in greater improvements in mood
and executive functioning than participants in a sham condition
(Zeidan et al., 2010a). Other studies have found improvements
in mood, cognition, and cardiovascular variables after brief, one-
time instructions in mindfulness (Broderick, 2005; Arch and
Craske, 2006; Zeidan et al., 2010b).
In the context of addiction, mindfulness meditation is
hypothesized to increase one’s ability to maintain a non-reactive
mindset when confronted with stress and/or cravings (Brewer
et al., 2009, 2010). Treatments for substance use disorders (Bowen
et al., 2009; Brewer et al., 2009), and particularly smoking ces-
sation (Cropley et al., 2007; Davis et al., 2007; Brewer et al.,
2011), have integrated mindfulness meditation with promis-
ing results. For example, college students who received brief
(11minutes) mindfulness-based instructions smoked signifi-
cantly fewer cigarettes one week later, compared to those who did
not receive instructions (Bowen and Marlatt, 2009). Additionally,
among individuals participating in a mindfulness training for
smoking cessation study, the frequency of meditation practice was
associated with reduced smoking (Brewer et al., 2011). Further,
individuals with substance use disorders who received mindful-
ness training showed increased parasympathetic output during
stress compared to those who received cognitive behavioral ther-
apy (Brewer et al., 2009). Together, these results suggest that the
increased HF-HRV that has been observed during meditation
may reflect increased self-regulation capacity or replenishment
of depleted self-control resources, which may in turn contribute
to the positive effects of mindfulness-based interventions in the
treatment of substance-use disorders.
Tobacco dependence is associated with impulsiveness and
deficits in self-regulation (Sayette, 2004; Flory and Manuck,
2009). Meditation-induced changes in HF-HRV, on the other
hand, may be indicative of the capacity to actively modulate reac-
tivity during stressful states such as during cravings for cigarettes
(Thayer et al., 2009). Importantly, a recent study demonstrated
that blunted HF-HRV reactivity in response to stress pre-
dicted decreased ability to resist the urge to smoke, as well as
increased reinforcement from smoking (Ashare et al., 2012).
While research has attempted to understand how stress-induced
changes in HF-HRV are associated with clinical outcomes,
there have been no studies examining the effects of changes
in HF-HRV in response to health-enhancing strategies such as
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meditation or relaxation. Also, to date, no studies have exam-
ined whether changes in HF-HRV during meditation are asso-
ciated with smoking cessation outcomes. The ability to increase
HF-HRV during periods of meditative or relaxed states may
hold predictive power beyond that of stress-induced changes in
HF-HRV.
In this exploratory study, we assessed whether resting HF-
HRV or acute HF-HRV changes during mindfulness meditation
were associated with smoking outcomes in a combined group of
novice meditators and individuals who had received four weeks
of mindfulness training for smoking cessation. As previous stud-
ies have demonstrated that individuals can learn to meditate
with minimal instruction and that inter-individual variability in
the ability to meditate exists in individuals who have received
meditation instruction, we sought to determine if physiological
changes during meditation were more predictive of outcomes
than length of training. In other words, we were interested in
whether acute changes in HF-HRV during meditation, regard-
less of length of training, could predict whether individuals
would reduce smoking behavior. Consistent with earlier research
that higher baseline HF-HRV and HF-HRV flexibility may both
be markers of inhibitory behavioral control, we examined four
hypotheses: (1) higher baseline levels of HF-HRV will be asso-
ciated with fewer cigarettes smoked at 17-week follow-up; (2)
increases in HF-HRV compared to decreases from resting baseline
to meditation will be associated with fewer cigarettes smoked at
17-week follow-up (3) HF-HRV during meditation will be asso-
ciated with fewer cigarettes smoked at 17-week follow-up; (4)
larger increases in HF-HRV from resting baseline to meditation
condition will be associated with number of cigarettes smoked at
17-week follow-up.
MATERIALS ANDMETHODS
PARTICIPANTS
Participants in the current study were a subsample of individu-
als recruited for a randomized controlled trial (RCT) of smoking
cessation treatment. Participants of the larger RCT were recruited
through flyers and media advertisements. Eligible participants
were 18–60 years of age, smoked 10 ormore cigarettes per day, had
little or no prior meditation experience, and reported motivation
to quit smoking. Exclusion criteria included current psychiatric
medication, serious or unstable medical condition in the past six
months, or other substance dependence in the past year.
Before randomization into treatment arms of a 4-week RCT
that compared Mindfulness Training for Smoking with the
American Lung Association’s Freedom From Smoking treatment,
a subsample of 34 participants (38.6% of the RCT) agreed to
participate in a functional magnetic resonance imaging (fMRI)
meditation laboratory session at the end of the treatment phase
of the study (fMRI data will be presented elsewhere). Thirty-one
participants provided valid data for analyses. Participants in the
current study did not significantly differ from non-participants in
age, gender, number of cigarettes smoked the week before treat-
ment, or age of smoking initiation (all p′s > 0.05). The study was
approved by the Yale University and Connecticut Veterans Affairs
Healthcare System institutional review boards. All participants
provided written informed consent.
SMOKING ASSESSMENT
Average number of daily cigarettes smoked during the week
before treatment initiation, the week before the laboratory
session, and the week before the 17-week follow-up were assessed
at in-person visits by a research assistant using the Timeline
Follow Back (TLFB) method (Sobell and Sobell, 1992). Self-
reported abstinence was assessed using TLFB and verified by an
exhaled carbonmonoxide measurement of ≤ 10 parts per million
(Benowitz et al., 2002).
LABORATORY PROCEDURE
Within two weeks of treatment completion, subjects participated
in a 1.5 h laboratory session that included practicing meditation
while supine in an fMRI scanner. Participants were instructed in
two standard mindfulness meditations: (1) Mindfulness of the
breath (“Please pay attention to the physical sensation of the
breath wherever you feel it most strongly in the body. Follow
the natural and spontaneous movement of the breath, not try-
ing to change it in any way. Just pay attention to it. If you find
that your attention has wandered to something else, gently but
firmly bring it back to the physical sensation of the breath.”);
and (2) Loving-kindness (“please think of a time when you gen-
uinely wished someone well. Using this feeling as a focus, silently
wish all beings well, by repeating a few short phrases of your
choosing.”) (Gunaratana, 2002). Subjects practiced each medita-
tion before the laboratory session and confirmed that they could
follow the instructions. Each run consisted of a 2min baseline
period (“please close your eyes and don’t think of anything in par-
ticular”), a 30 s recorded meditation instruction (as above), and
a 4.5min meditation period. Subjects performed each meditation
twice in a blocked randomorder (i.e., AABB). After each run, par-
ticipants rated how well they were able to follow the instructions
during each meditation period (0–10). After the last meditation,
participants rated their level of anxiety (0–10).
HRV ACQUISITION AND PROCESSING
Heart rate was recorded using a pressure transducer attached to
each participant’s non-dominant thumb. This method has been
previously shown to accurately capture interbeat variability that
is comparable to standard Electrocardiography and was pilot-
tested in our laboratory using simultaneous pulse transduction
and ECG before proceeding (Heilman et al., 2008). A Biopac
MP150 pressure transduction system running AcqKnowledge
4.1 software (Biopac Systems, USA), with a 1000Hz sample rate
and 1Hz high band pass filter, was used for acquiring and pro-
cessing heart rate data. Heart rate waveforms were analyzed to
determine appropriateness for spectral analysis and deviant inter-
beat intervals were identified and edited by visual inspection
according to current guidelines (Task Force, 1996). For heart rate
data to be considered valid, the waveforms were required to have
at least 120 consecutive seconds of identifiable HR data with
no more than four consecutive, and no more than 20% total,
interpolated beats. HF-HRV was defined as the power in the fre-
quency range of 0.15Hz to 0.4Hz (Task Force, 1996). Spectral
estimates of power were logarithmically transformed to normalize
the distribution of scores. Two consecutive 2min segments were
derived from each of the meditation periods and averaged so that
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comparisons could be made with our two-minute baseline peri-
ods; two minute periods have been shown to provide sufficient
data for the analysis of HRV (Task Force, 1996; Berntson et al.,
1997). There were no differences in HF-HRV between the two
types of meditation (p = 0.772), and thus they were combined
into a single variable for analysis. HF-HRV values from baseline
were subtracted from meditation values to derive an HF-HRV
change score (change = meditation – baseline).
Respiration rate was recorded using a pressure transducer
affixed to the lower thorax via an elastic band. The BiopacMP150
system running AcqKnowledge 4.1 software (Biopac Systems,
USA), was used for acquiring and processing respiration rate data.
Although there are differences of opinion regarding the need to
account for respiration when quantifying parasympathetic out-
put, HF-HRV uncorrected for respiration is accepted as a valid
index of cardiac parasympathetic control when there are no task
differences in respiration (Denver et al., 2007; Grossman and
Taylor, 2007), and is a meaningful index of cardiorespiratory
control that has predictive power independent of the underly-
ing parasympathetic mechanisms (Ritz and Dahme, 2006; Egizio
et al., 2011). In our sample, there were no differences in respira-
tion rate between baseline and meditation periods (t = −0.184,
p = 0.855) and thus HF-HRV data are presented without respira-
tory adjustment.
STATISTICAL ANALYSIS
Statistical analyses were performed in SPSS 18.0. Three outlying
cases with HF-HRV data greater than three standard deviations
below the mean were excluded before further analysis.
We constructed four linear regression models with average
number of daily cigarettes smoked at week 17 as the outcome. The
main predictor variables in models 1, 2, 3, and 4 were baseline
HF-HRV, direction of HF-HRV change (increase or decrease),
HF-HRV during meditation, and magnitude of HF-HRV change,
respectively. All models included age, gender, and smoking behav-
ior both at pre- and post-treatment as a priori covariates because
they are known to be associated with HF-HRV (Hayano et al.,
1990; Britton et al., 2007). Treatment group was also added as
a covariate in each of the models, and baseline HF-HRV was
included as a covariate in models 2, 3, and 4 (Jennings and
Gianaros, 2007). All tests are two-tailed; Bonferroni correction
was used to control for Type I error associated with multiple com-
parisons; therefore, significance is reported as p = 0.0125 (Rom,
1990).
RESULTS
PARTICIPANT DEMOGRAPHICS
Participants’ demographic characteristics are presented in
Table 1. Overall, 46% of participants were members of ethnic
minority groups, and 64% were men. On average, participants
were 48 years old, smoked 19 cigarettes per day, started smoking
regularly at the age of 17, and had 5.9 previous quit attempts.
MANIPULATION CHECK
Participants reported that they were able to follow instructions to
a high degree (Mean = 7.3 ± 2.2 on a 0–10 Likert scale). There
was no relationship between participant ratings and baseline
Table 1 | Pre-treatment characteristics of participants.
Participants (n = 28)
SEX N (%)
Male 18 (64.3)
Female 10 (35.7)
AGE 48.00 (8.93)
RACE
White 15
Black 11
Hispanic 2
EDUCATION LEVEL
College grad or more 17
Partial college 2
High school 9
Mean (SD)
Started smoking 3x/week (age) 16.61 (4.25)
Number of cigarettes/day 18.86 (8.30)
Number of prior quit attempts 5.86 (7.78)
Table 2 | Mean HF-HRV values in normalized units (n.u.)
Mean (SD) Range
Mean baseline HF-HRV 6.477 (0.257) 5.747−7.018
Mean HF-HRV during meditation 6.490 (0.254) 5.756−6.998
Mean HF-HRV change score 0.0111 (0.063) −0.170−0.1264
HF-HRV (r = 0.022, p = 0.912) or changes in HF-HRV dur-
ing meditation (r = −0.013, p = 0.949). Participants reported
mild-moderate anxiety in the scanner (4.1 ± 2.6).
GROUP DIFFERENCES IN HF-HRV
Independent-samples t-tests indicated that there were no differ-
ences between individuals who received mindfulness training and
those who received Freedom From Smoking in baseline HF-HRV,
HF-HRV during the meditations, or mean HF-HRV meditation
reactivity, all p’s > 0.05.
HF-HRV AS A PREDICTOR OF SMOKING OUTCOMES
Table 2 presents the mean and range of average HF-HRV during
baseline, meditation, and the magnitude of change from baseline
to meditation. There were no significant differences in HF-HRV
between baseline and meditation (t(27) = −0.954, p = 0.349),
indicating that on average, there was no acute change in HF-HRV.
However, participants were significantly more likely to exhibit an
increase in HF-HRV than a decrease in HF-HRV from resting
baseline to meditation; Twenty of 28 participants (71.4%) exhib-
ited an average increase, and eight participants (28.6%) exhibited
an average decrease in HF-HRV from baseline to meditation
(χ2(1) = 5.14, p = 0.023).
After adjustment for covariates, HF-HRV during baseline was
not significantly associated with number of cigarettes smoked
at week 17 (b = 5.028, SE = 3.783, r2 = 0.035, p = 0.198).
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The models predicting number of cigarettes smoked at week 17
from HF-HRV during meditation (b = −27.016, SE = 13.494,
r2 = 0.070, p = 0.059), and from the magnitude of change
in HF-HRV (b = −30.555, SE = 13.916, r2 = 0.082, p =
0.040), approached, but did not reach statistical significance after
correction for multiple comparisons. However, when change in
HF-HRV was dichotomized by direction of change (increase vs.
decrease), regression analyses showed that this significantly pre-
dicted the number of cigarettes smoked per day at week 17, inde-
pendently of the effects of age, gender, treatment group, number
of cigarettes smoked the week prior to treatment initiation, num-
ber of cigarettes smoked the week prior to the laboratory session,
and baseline HF-HRV (b = −4.89, SE = 1.65, r2 = 0.128, p =
0.008). These results did not meaningfully change when anxiety
ratings were added to the model. Twenty percent of participants
who exhibited an increase in HF-HRV and 12.5% of partici-
pants who exhibited a decrease in HF-HRV achieved smoking
abstinence at week 17, as verified by exhaled carbon monox-
ide measurement of = 10 ppm (sample size insufficient for χ2
analysis).
DISCUSSION
In sum, one of our four hypotheses was definitively supported,
two had moderate support and one was refuted. In the cur-
rent study, individuals who demonstrated an increase in HF-
HRV from baseline to meditation smoked significantly fewer
cigarettes 17-weeks after treatment initiation, compared to those
who demonstrated a decrease in HF-HRV. The magnitude of
this change and HF-HRV during meditation was each moder-
ately associated with smoking outcomes, while baseline levels of
HF-HRV were not predictive of smoking outcomes.
The differential autonomic responses to the meditation con-
ditions may be reflective of the inter-individual variability in
HF-HRV reactivity in response to meditation. Previous studies
of both novice and experienced meditators have shown aver-
age increases in HF-HRV during meditation, although individ-
ual differences in the direction of change have been reported
(Lehrer et al., 1999; Takahashi et al., 2005; Peressutti et al., 2010).
Consistent with these reports, we found that 71% of participants
showed increased HF-HRV. The decrease in HF-HRV among
some participants may have been due to the mildly stressful envi-
ronment of the laboratory. Importantly, an increase, compared
to a decrease in HF-HRV was significantly associated with sub-
sequent reduced cigarette consumption, while HF-HRV during
baseline, during meditation, and the magnitude of change from
baseline to meditation were not. This is consistent with the idea
that direction of phasic HF-HRV change during a meditation
exercise is associated with psychological health (Rockliff et al.,
2008). Although preliminary, these results suggest that the ability
to bring autonomic activity into a parasympathetically-dominant
state while meditating may be a more significant predictor of sub-
stance use outcomes than tonic levels of autonomic activity or
magnitude of change. As noted above, the magnitude of change
in HF-HRV was marginally significantly associated with smoking
outcomes. Future research should use larger samples to replicate
these results and to examine whether magnitude of increase may
also relate to smoking outcomes.
There were no differences in any of the HF-HRV measures
between novices and individuals who received 4-weeks of mind-
fulness training. This is consistent with the notion that individu-
als can learn to meditate without long periods of training (Zeidan
et al., 2010b; Moyer et al., 2011). This also suggests, however, that
4-weeks of practice may not be sufficient for some individuals to
achieve the ability to drop into a parasympathetically-dominated
psychophysiological state during meditation. As indicated by
moderate levels of anxiety reported while in the fMRI scanner,
this environment may be a sufficient provocateur for differen-
tiating individuals who have this capacity from those who do
not, regardless of previous mindfulness training. As such, HF-
HRV changes from baseline to meditation in a mildly stressful
environment may be a potential biomarker or predictor for indi-
viduals who are more likely to be successful in quitting smoking.
Given previous research suggesting that HF-HRVmay index self-
regulatory capacity, those individuals who exhibited increases in
HF-HRV when meditating may have the self-control resources
necessary to inhibit habitual smoking behaviors. If these results
are replicated, future smoking cessation studies may be able to use
similar, non-invasive measures to individualize target quit dates,
waiting until meditation during mild stress results in a consistent
increase in HF-HRV before committing to a quit date. Tailoring
quit dates to match self-regulatory capacity may reduce relapses
and minimize failure experiences resulting in improved smoking
cessation outcomes.
There are several limitations of this study. First, it was con-
ducted with a subsample of participants from a larger RCT.
Therefore, we may have been underpowered to detect effects of
HF-HRV during baseline and/or meditation on smoking out-
comes. A larger sample size may be better suited to detect whether
these predict smoking outcomes as well. Second, the reported
association may not be specific to mindfulness meditation; other
tasks that result in an acute increase in HF-HRV may pro-
duce similar results. Future research comparing the predictive
power of acute HF-HRV increases in response to other medita-
tive or relaxation tasks is warranted. In addition, future studies
should include comparisons between the predictive power of
stress-induced (Ashare et al., 2012) versus meditation-induced
changes in HF-HRV. Third, the meditation laboratory session
occurred after a 4-week smoking cessation study. Future stud-
ies that assess HF-HRV at both pre- and post-treatment may
more precisely elucidate potential relationships between changes
in parasympathetic output during treatment and subsequent out-
comes. Finally, although our results are consistent with proposed
mechanisms of mindfulness and prefrontal inhibition of habitual
smoking behavior, we did not directly measure these constructs.
The mechanisms through which HF-HRV changes from baseline
to meditation may predict smoking outcomes might be further
clarified by combining these measures with others, such as eco-
logical momentary assessment of coping responses to stress and
cravings.
In conclusion, this study demonstrated that meditation more
often resulted in an acute increase in HF-HRV than a decrease
in HF-HRV in a nicotine-dependent sample. Importantly, we
showed for the first time that individuals exhibiting an increase
in HF-HRV while meditating had better smoking outcomes three
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months later, compared to those who exhibited a decrease in
HF-HRV. These findings, although preliminary, suggest that mea-
surements of acute HF-HRV changes during meditation show
promise as a non-invasive biomarker and predictor of smoking
cessation treatment.
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